Search Results 731-740 of 18302 for SARS
SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative study. Immunol Res. 2023 Oct; 71 (5):717-724 Epub ...
... SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...
JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.
Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience. Mod Pathol. 2021 Aug; 34(8):1456-1467. Epub 2021 Apr 01. View PubMed; Wagaskar VG ...
Subject has a positive reverse transcriptase-PCR diagnostic test for SARS-CoV-2 within the 14 days prior to screening. Subject has uncontrolled hypertension ...
SARS-CoV-2 infection increases risk of acute kidney injury in a bimodal age distribution. BMC Nephrol. 2022 Feb 11; 23(1):63. View PubMed; Bohman JK, Nei SD ...
Central Sensitization Phenotypes in Post Acute Sequelae of SARS-CoV-2 Infection (PASC): Defining the Post COVID Syndrome. J Prim Care Community Health. 2021 ...
The FDA authorized the Convalescent Plasma Expanded Access Program for the use of convalescent plasma for patients infected with SARS-CoV-2, the virus that ...
Coronavirus disease 2019 (COVID-19) and seasonal flu are illnesses caused by viruses. They can spread from one person to another.
The purpose of this study is to determine the safety of the SARS-CoV-2 vaccination in patients listed for solid organ transplantation, including heart, lung, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.